RE covery and SUR vival of patients with moderate to severe acute RE spiratory distress syndrome (ARDS) due to C OVID-19: a multicenter, single-arm, Phase IV itolizumab T rial: RESURRECT
Kr, Raveendra, Rathod, Chirag, Darnule, Rahul, Loganathan, Subramanian, Deodhar, Sarika, A, Radhika, Marwah, Ashwani, Chaudhari, Nitin M, Thakur, Binay K, Vaidyanathan, Sivakumar, Athalye, Sandeep Nilkanth
Published in Expert opinion on biological therapy (04.05.2023)
Published in Expert opinion on biological therapy (04.05.2023)
Get more information
Journal Article